Literature DB >> 18475738

alpha(2)-macroglobulin and alpha(1)-inhibitor-3 mRNA expression in the rat liver after slow interleukin-1 stimulation.

T Gudmundsson1, P Björk, K Ohlsson.   

Abstract

In this study we have investigated total fiver RNA and the expression of mRNA in the rat fiver in vivo after a slow stimulation of interleukin-1. A total dose of 4 mug interleukin-1beta was administered via a subcutaneously implanted osmotic minipump over a period of 7 days. Plasma concentrations of alpha(2)-macroglobulin manifested a rapid increase, reaching a peak on day 2, while alpha(1)-inhibitor-3 manifested a marked initial decrease to 50% of the baseline level, followed by a tendency to increase again. For measurement of total RNA and specific mRNAs from the fiver, rats were sacrificed at different times during the experimental period. Total RNA peaked at 6 h, the level being approximately 60% higher than baseline value. Specific mRNA from the liver for alpha(2)-macroglobulin and alpha(1)-inhibitor-3 were quantified using laser densitometry on slot blots. The amounts measured during the experimental period agreed with the pattern of corresponding plasma protein levels. From barely detectable amounts at baseline, alpha(2)-macroglobulin mRNA peaked on day 1, and then declined. Levels of alpha(1)-inhibitor-3 mRNA manifested an initial increase at 3 h, but then declined and remained low until day 5 when there was a tendency towards an increase. It was concluded that the levels of plasma concentrations of alpha(2)-macroglobulin and alpha(1)-inhibitor-3 are mainly regulated at the protein synthesis level, and that long-term interleukin-1beta release could not override the initial acute phase protein counteracting mechanism triggered.

Entities:  

Year:  1996        PMID: 18475738      PMCID: PMC2365808          DOI: 10.1155/S0962935196000385

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  21 in total

1.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

2.  Isolation of rat serum alpha 1-microglobulin. Identification of a complex with alpha 1-inhibitor-3, a rat alpha 2-macroglobulin homologue.

Authors:  C Falkenberg; A Grubb; B Akerström
Journal:  J Biol Chem       Date:  1990-09-25       Impact factor: 5.157

Review 3.  Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation.

Authors:  H Baumann; J Gauldie
Journal:  Mol Biol Med       Date:  1990-04

4.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.

Authors:  K Ohlsson; P Björk; M Bergenfeldt; R Hageman; R C Thompson
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

5.  Changes in hepatic RNA, poly(A)+RNA, and poly(A)-RNA during the acute phase response to inflammation.

Authors:  S Demczuk; A M Chandler
Journal:  Biochem Int       Date:  1986-01

6.  Sequence of rat liver alpha 2-macroglobulin and acute phase control of its messenger RNA.

Authors:  M R Gehring; B R Shiels; W Northemann; M H de Bruijn; C C Kan; A C Chain; D J Noonan; G H Fey
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

7.  Three high molecular weight protease inhibitors of rat plasma. Isolation, characterization, and acute phase changes.

Authors:  K Lonberg-Holm; D L Reed; R C Roberts; R R Hebert; M C Hillman; R M Kutney
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

8.  Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor.

Authors:  E V Granowitz; B D Clark; J Mancilla; C A Dinarello
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

9.  Acute phase protein response and polymorphonuclear leukocyte cathepsin g release after slow interleukin-1 stimulation in the rat.

Authors:  P Björk; T Gudmundsson; K Ohlsson
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

10.  The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse.

Authors:  P Bjrök; K Ohlsson
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.